Brii Biosciences Limited (7SS) — Financial Flexibility Index
Brii Biosciences Limited (7SS) has a Financial Flexibility Index of -5.85x as of December 2025. Free cash flow of €-211.82 Million (operating CF €-338.81 Million minus capex €126.99 Million) represents -6% of total liabilities (€36.20 Million). Also explore 7SS net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Brii Biosciences Limited Financial Flexibility Index (2020–2025)
Historical Financial Flexibility Index trend for Brii Biosciences Limited across 6 annual periods. Check 7SS cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for Brii Biosciences Limited (2020–2025)
Year-by-year free cash flow to debt coverage for Brii Biosciences Limited. For the full company profile including market capitalisation, see Brii Biosciences Limited market capitalisation.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -5.85x | €-211.82 Million | €-338.81 Million | €36.20 Million | ▼ -59.1% |
| 2024 | -3.68x | €-369.66 Million | €-372.89 Million | €100.55 Million | ▲ +15.0% |
| 2023 | -4.33x | €-544.41 Million | €-594.01 Million | €125.87 Million | ▼ -183.9% |
| 2022 | -1.52x | €-356.99 Million | €-496.28 Million | €234.35 Million | ▲ +47.9% |
| 2021 | -2.92x | €-878.43 Million | €-879.46 Million | €300.44 Million | ▼ -2080.4% |
| 2020 | -0.13x | €-403.72 Million | €-403.72 Million | €3.01 Billion | — |